Pressroom

 

Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

Thousands of oncology experts from around the world will gather in Atlanta from March 29 – April 3 for the American Association for Cancer Research (AACR) Annual Meeting 2019. Memorial Sloan Kettering experts are involved in notable research presented at the meeting and are available to comment on topics including immunotherapy, precision medicine and targeted treatments, genomics, cancer interception and prevention, clinical trial design, cancer health disparities, and more. For more information and to set up interviews or access photos and video, contact mcnamarn@mskcc.org and odonnele@mskcc.org.
Thursday, March 28, 2019
 
Using genetic engineering, Memorial Sloan Kettering Cancer Center (MSK) physician-scientist Christopher Klebanoff, MD, has led a team of researchers to create a “cloak” that protects cancer-fighting T white blood cells, such as chimeric antigen receptor T cells, from self-destructing. During cancer immunotherapy, immune cells often undergo a form of cellular suicide, termed apoptosis, which can limit the therapy’s effectiveness. The use of “genetic cloaking” prevents immune cell apoptosis, enhancing the effectiveness of cellular immunotherapies for liquid and solid cancers in mouse models. This new technique is also effective in protecting human cancer-fighting immune cells. These findings lay the groundwork for a potentially universal gene-engineering strategy to safely increase the potency of cellular immunotherapies for a broad range of cancers.
Tuesday, January 29, 2019
 
Doctors have had limited success developing targeted therapies for the treatment of glioblastoma and lower-grade glioma, the most common primary brain cancers in adults. Targeted therapy requires matching drugs to the genetic profile of a tumor, which can substantially change throughout the course of the disease. Keeping track of these changes is particularly challenging in people with brain tumors because collecting tumor DNA requires brain surgery. But experts from MSK have shown that utilizing the minimally invasive procedure commonly called a spinal tap may help doctors better understand a tumor’s changing genetic makeup, offering clues into such traits as tumor aggressiveness.
Wednesday, January 23, 2019
 

See all trending topics
 

Press Releases

 

Michael P. Harrington has been named Executive Vice President and Chief Financial Officer (CFO) at Memorial Sloan Kettering Cancer Center (MSK). Mr. Harrington currently serves as the Associate Chief Financial Officer at the Cleveland Clinic. His appointment concludes a national search to identify a successor for MSK’s current CFO, Michael Gutnick, who will retire after 42 years of exemplary service to MSK.
Wednesday, April 10, 2019
 
Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location, and its third on Long Island, will open for patient care on April 8 with more than 180 dedicated medical and professional staff, all of whom are MSK employees.
Thursday, April 4, 2019
 
The Starr Foundation is continuing its longstanding commitment to stem cell research in New York City with a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), a research collaboration between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine.
Thursday, April 4, 2019
 

See all press releases
 

On Our Blog

 

IN THE NEWS
We love our smartphones, but could they be harming our health? An MSK expert weighs in.
Monday, May 20, 2019
 
IN THE CLINIC
Learn how MSK doctors are using proton therapy to treat tumors of the brain and spinal cord.
Friday, May 17, 2019
 
IN THE LAB
A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.
Monday, May 13, 2019
 

See all blog posts
 

Media Coverage

 

Nearly 50 years ago, MSK’s Richard O’Reilly began his career as a pediatric oncologist at Memorial Sloan Kettering. Considered the “God of bone marrow transplantation,” Dr. O’Reilly’s research has been instrumental in forever changing the course of cancer treatment. In this episode of LIFERS, find out why he believes that a cure for this disease, which affects one in three people, is on its way. MSK’s Michael La Quaglia and Julianne Ruggiero are interviewed.
Tuesday, May 7, 2019
 
Memorial Sloan Kettering Nassau opened its new Uniondale location Monday, greatly expanding the highly regarded Manhattan-based cancer center’s Long Island presence that aims to make treatment more easily accessible to local patients. MSK’s Craig Thompson, Lisa DeAngelis and patient are quoted.
Wednesday, April 10, 2019
 
Memorial Sloan Kettering Cancer Center’s new facility in Uniondale will be open for business Monday morning. The 114,000-square-foot outpatient facility, newly constructed in the parking lot of Nassau Coliseum, was unveiled Thursday in a dedication ceremony, which was attended by about 300 people. MSK’s Craig Thompson, Oren Cahlon, and Pamela Drullinsky are quoted.
Friday, April 5, 2019
 

See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Media Relations Manager, Surgery
 
Courtney Nowak
Media Relations Manager, Regional Care Network
 
Caitlin Hool
Senior Manager, Media Relations and Partnerships
 
Nicole H. McNamara
Senior Media Strategist
 
Rebecca Williams
Media Strategist
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.